These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15001277)

  • 41. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Discusses on the multimodality therapy of hepatocellular carcinoma].
    Dou KF; Li BD
    Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1011-4. PubMed ID: 17074233
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?
    Majno P; Giostra E; Mentha G
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S27-35. PubMed ID: 17969086
    [No Abstract]   [Full Text] [Related]  

  • 44. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M; Wu PH; Zeng YX; Xia JC; Zhang FJ; Xian LJ; Zhang YP; Zhou K; Fan WJ; Zhang L; Gao F; Zhou QM
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1823-8. PubMed ID: 17054858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
    Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L;
    Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Standard therapy for primary hepatocellular carcinoma].
    Ye SL
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):449-50. PubMed ID: 15329199
    [No Abstract]   [Full Text] [Related]  

  • 48. Hepatocellular carcinoma presenting as paraneoplastic myasthenia gravis.
    Vautravers C; Rat P; Cercueil JP; Moreau T; Horiot JC; Chauffert B
    Eur J Intern Med; 2008 Dec; 19(8):e86-7. PubMed ID: 19046712
    [No Abstract]   [Full Text] [Related]  

  • 49. [A case of diffuse invasive hepatocellular carcinoma associated with thrombosis of the main trunk of the portal vein in which hepatic transcatheter arterial chemoembolization concomitant to the use of degradable starch microspheres (DSM-TACE) was very effective].
    Shitara K; Fukunari H; Fujimori Y; Sho O; Hayashi T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1807-10. PubMed ID: 17212114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up].
    Haruno M; Shimamura R; Ogawa Y; Tanaka H; Sakai K; Araki K
    Gan To Kagaku Ryoho; 2005 May; 32(5):667-70. PubMed ID: 15918569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization.
    Flohr F; Harder J; Seufert J; Blum HE; Spangenberg HC
    Hepatology; 2008 Jun; 47(6):2144. PubMed ID: 18459123
    [No Abstract]   [Full Text] [Related]  

  • 52. How to manage hepatic vein tumour thrombus in hepatocellular carcinoma.
    Okada S
    J Gastroenterol Hepatol; 2000 Apr; 15(4):346-8. PubMed ID: 10824876
    [No Abstract]   [Full Text] [Related]  

  • 53. Preservation of segment 4 inferior by distal middle hepatic vein reconstruction combined with extended right hepatectomy after portal vein embolization in a patient with a huge initially unresectable HCC.
    Nakano H; Kikuchi K; Seta S; Katayama M; Yamamura T; Otsubo T
    Hepatogastroenterology; 2007; 54(77):1563-6. PubMed ID: 17708300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma.
    Kaibori M; Tanigawa N; Matsui Y; Kwon AH; Sawada S; Kamiyama Y
    Anticancer Res; 2004; 24(3b):1929-33. PubMed ID: 15274379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficacy of postoperative chemotherapy combined with immunotherapy for hepatocellular carcinoma with major portal vein tumor thrombus].
    Hu WJ; Liang LJ; Zhou Q; Peng BG; Yin XY; Li DM
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1325-7. PubMed ID: 18241566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Approaches for interventional therapy of hepatoma].
    Guan YS; Yang L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):785. PubMed ID: 16248956
    [No Abstract]   [Full Text] [Related]  

  • 57. [Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma].
    Li CX; Zhang Y; Gao L
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):942-5. PubMed ID: 17533749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
    Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transarterial chemoembolization for hepatocellular carcinoma.
    Lau WY; Yu SC; Lai EC; Leung TW
    J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.